Xenon appoints Tucker Kelly as CFO; grants 225K options, 30K RSUs

Xenon Pharmaceuticals Inc.

Tucker Kelly named CFO effective Oct 15, 2025; previously CFO at Deciphera (acquired by Ono for $2.4B).
Annual base salary $540K; eligible for incentive up to 45% of base.
One-time inducement grant: options for 225K shares at $41.90 (closing price Oct 15).
One-time grant of 30,000 RSUs; both options and RSUs vest over 4 years.
Interim CFO Ian Mortimer steps down but remains President & CEO as lead candidate azetukalner enters Phase 3.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.